Delivery Order SPE2DR25D3007-SPE2DR26F0MC2

The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,682.60 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, issued on January 20, 2026, with an ultimate completion date of January 21, 2026, represents a task order executed under a larger indefinite delivery contract vehicle. The award was competitively awarded with no set-aside designation, demonstrating the contractor's ability to meet federal procurement requirements through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters.

This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This prime contract vehicle serves as the comprehensive global pharmaceutical support mechanism enabling the delivery of a broad spectrum of pharmaceutical products and medical supplies to military healthcare programs worldwide. The DLA contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, supporting critical medical procurement needs for the Defense Health Agency and other federal healthcare systems.